Don't drink too much Kool Aid. They've done this conference yearly. You still have to come to grips with the possibility that TEVA withdrawing its rights to license to 3117 was a negative event. I don't think any partnerships will be announced. I would be interested on seeing if the CEO puts a spin on the Teva news. That will be interesting.